Here’s a comparison of HOMA-IR and the HOMA-IR C-peptide model, presented in a tabular format to highlight their differences, use cases, and relative strengths:
| Feature | HOMA-IR (Standard) | HOMA-IR C-peptide Model |
|---|---|---|
| Basis of Calculation | Uses fasting insulin and glucose levels | Uses fasting C-peptide and glucose levels |
| Formula | HOMA-IR = (Fasting Insulin [μU/mL] × Fasting Glucose [mmol/L]) / 22.5 | HOMA-IR<sub>C-peptide</sub> ≈ (Fasting C-peptide [pmol/L] × Fasting Glucose [mmol/L]) / constant* |
| What It Estimates | Hepatic insulin resistance (primarily) | Whole-body insulin resistance (more reflective of endogenous insulin secretion) |
| Insulin Measurement Required? | Yes | No — uses C-peptide instead |
| Advantages | – Widely validated – Standard in clinical & research settings – Simple and cost-effective | – More stable than insulin (less pulsatile, longer half-life) – Better in conditions with altered insulin clearance (e.g., liver/kidney disease) – Useful when insulin assays are unreliable |
| Limitations | – Insulin assays vary across labs – Affected by insulin clearance/metabolism – Less reliable in advanced diabetes or beta-cell failure | – Less standardized reference ranges – Not as widely adopted clinically – Requires conversion factors; less historical data |
| Best Used When | – General population screening – Early insulin resistance assessment – Large epidemiological studies | – Insulin assay unavailable/unreliable – Patients with hepatic/renal impairment – Research on beta-cell function + IR simultaneously |
| Clinical Adoption | High (gold standard surrogate for IR) | Low to moderate (mostly research or specialized settings) |
* Note: The exact constant in the C-peptide version varies by study; common approximations exist but lack universal standardization like the original HOMA-IR.
Which is Best?
- For routine clinical use, the standard HOMA-IR is preferred due to its widespread validation, established cutoffs (e.g., >2.0 or >2.5 indicating insulin resistance), and ease of interpretation.
- For research or specific clinical scenarios (e.g., renal failure, inconsistent insulin assays, or when assessing endogenous insulin secretion): the C-peptide–based model may offer more reliable insights.
✅ Bottom line: Use standard HOMA-IR unless you have a specific reason (like unreliable insulin measurements or altered insulin metabolism) to prefer the C-peptide version.